Targeting focal adhesion kinase in cancer cells and the tumor microenvironment
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting focal adhesion kinase in cancer cells and the tumor microenvironment
Authors
Keywords
-
Journal
EXPERIMENTAL AND MOLECULAR MEDICINE
Volume 52, Issue 6, Pages 877-886
Publisher
Springer Science and Business Media LLC
Online
2020-06-09
DOI
10.1038/s12276-020-0447-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- FAK signaling in cancer-associated fibroblasts promotes breast cancer cell migration and metastasis by exosomal miRNAs-mediated intercellular communication
- (2020) Hsin-Jung Wu et al. ONCOGENE
- T-cell co-stimulation in combination with targeting FAK drives enhanced anti-tumor immunity
- (2020) Marta Canel et al. eLife
- Phase I Study of BI 853520, an Inhibitor of Focal Adhesion Kinase, in Patients with Advanced or Metastatic Nonhematologic Malignancies
- (2019) Maja J. A. de Jonge et al. Targeted Oncology
- Direct Interactions With Cancer-Associated Fibroblasts Lead to Enhanced Pancreatic Cancer Stem Cell Function
- (2019) Asma Begum et al. PANCREAS
- FAK inhibition reduces metastasis of α4 integrin-expressing melanoma to lymph nodes by targeting lymphatic VCAM-1 expression
- (2019) Kyuho Jeong et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Nuclear Focal Adhesion Kinase Controls Vascular Smooth Muscle Cell Proliferation and Neointimal Hyperplasia Through GATA4-mediated Cyclin D1 Transcription
- (2019) Kyuho Jeong et al. CIRCULATION RESEARCH
- Development of resistance to FAK inhibition in pancreatic cancer is linked to stromal depletion
- (2019) Hong Jiang et al. GUT
- WT1 associated protein promotes metastasis and chemo-resistance to gemcitabine by stabilizing Fak mRNA in pancreatic cancer
- (2019) Bing-Qi Li et al. CANCER LETTERS
- Tumor angiogenesis is differentially regulated by phosphorylation of endothelial cell focal adhesion kinase tyrosines-397 and -861
- (2019) Ana-Rita Pedrosa et al. CANCER RESEARCH
- The Tumor Microenvironment Innately Modulates Cancer Progression
- (2019) Dominique C. Hinshaw et al. CANCER RESEARCH
- FAK and Pyk2 activity promote TNF-α and IL-1β-mediated pro-inflammatory gene expression and vascular inflammation
- (2019) James M. Murphy et al. Scientific Reports
- Atezolizumab potentiates Tcell-mediated cytotoxicity and coordinates with FAK to suppress cell invasion and motility in PD-L1+ triple negative breast cancer cells
- (2019) Nishant Mohan et al. OncoImmunology
- The relationship between phosphorylation status of focal adhesion kinases, molecular subtypes, tumour microenvironment and survival in patients with primary operable ductal breast cancer
- (2019) Najla M. Andisha et al. CELLULAR SIGNALLING
- FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy
- (2019) Carlos J Diaz Osterman et al. eLife
- A Synergistic Anti-Cancer FAK and HDAC Inhibitor Combination Discovered by a Novel Chemical-Genetic High-Content Phenotypic Screen
- (2019) John C Dawson et al. MOLECULAR CANCER THERAPEUTICS
- Role of Focal Adhesion Kinase in Small-Cell Lung Cancer and Its Potential as a Therapeutic Target
- (2019) Frank Aboubakar Nana et al. Cancers
- Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape
- (2018) Max D. Wellenstein et al. IMMUNITY
- Understanding the tumor immune microenvironment (TIME) for effective therapy
- (2018) Mikhail Binnewies et al. NATURE MEDICINE
- Targeting the tumour stroma to improve cancer therapy
- (2018) Kenneth C. Valkenburg et al. Nature Reviews Clinical Oncology
- Cx26 drives self-renewal in triple-negative breast cancer via interaction with NANOG and focal adhesion kinase
- (2018) Praveena S. Thiagarajan et al. Nature Communications
- Nuclear FAK and its kinase activity regulate VEGFR2 transcription in angiogenesis of adult mice
- (2018) Shaogang Sun et al. Scientific Reports
- Efficacy of the highly selective focal adhesion kinase inhibitor BI 853520 in adenocarcinoma xenograft models is linked to a mesenchymal tumor phenotype
- (2018) Ulrich A. Hirt et al. Oncogenesis
- A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization
- (2018) Miguel F. Sanmamed et al. CELL
- Turning foes to friends: targeting cancer-associated fibroblasts
- (2018) Xueman Chen et al. NATURE REVIEWS DRUG DISCOVERY
- Cancer-associated fibroblast-derived Lumican promotes gastric cancer progression via the integrin β1-FAK signaling pathway
- (2017) Xiaofeng Wang et al. INTERNATIONAL JOURNAL OF CANCER
- Wnt/β-Catenin Pathway Activation Mediates Adaptive Resistance to BRAF Inhibition in Colorectal Cancer
- (2017) Guangming Chen et al. MOLECULAR CANCER THERAPEUTICS
- Elements of cancer immunity and the cancer–immune set point
- (2017) Daniel S. Chen et al. NATURE
- The extracellular matrix and focal adhesion kinase signaling regulate cancer stem cell function in pancreatic ductal adenocarcinoma
- (2017) Asma Begum et al. PLoS One
- Myosin-1E interacts with FAK proline-rich region 1 to induce fibronectin-type matrix
- (2017) Joel B. Heim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- IL-33 and ST2 mediate FAK-dependent antitumor immune evasion through transcriptional networks
- (2017) Bryan Serrels et al. Science Signaling
- IL-33 and ST2 mediate FAK-dependent antitumor immune evasion through transcriptional networks
- (2017) Bryan Serrels et al. Science Signaling
- A phase I, pharmacokinetic and pharmacodynamic study of GSK2256098, a focal adhesion kinase inhibitor, in patients with advanced solid tumors
- (2016) J. C. Soria et al. ANNALS OF ONCOLOGY
- Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy
- (2016) Hong Jiang et al. NATURE MEDICINE
- Nuclear FAK Controls Chemokine Transcription, Tregs, and Evasion of Anti-tumor Immunity
- (2015) Alan Serrels et al. CELL
- How Do Cytotoxic Lymphocytes Kill Cancer Cells?
- (2015) L. Martinez-Lostao et al. CLINICAL CANCER RESEARCH
- Emerging targets in cancer immunotherapy: beyond CTLA-4 and PD-1
- (2015) Amer Assal et al. Immunotherapy
- A phase I study of VS-6063, a second-generation focal adhesion kinase inhibitor, in patients with advanced solid tumors
- (2015) Suzanne F. Jones et al. INVESTIGATIONAL NEW DRUGS
- Targeting PYK2 mediates microenvironment-specific cell death in multiple myeloma
- (2015) M B Meads et al. ONCOGENE
- FAK signaling in human cancer as a target for therapeutics
- (2015) Brian Y. Lee et al. PHARMACOLOGY & THERAPEUTICS
- Pyk2 promotes tumor progression in multiple myeloma
- (2014) Y. Zhang et al. BLOOD
- Inhibition of endothelial FAK activity prevents tumor metastasis by enhancing barrier function
- (2014) Christine Jean et al. JOURNAL OF CELL BIOLOGY
- Understanding the Roles of FAK in Cancer
- (2014) Hyunho Yoon et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy
- (2014) Bernardo Tavora et al. NATURE
- Merlin Deficiency Predicts FAK Inhibitor Sensitivity: A Synthetic Lethal Relationship
- (2014) I. M. Shapiro et al. Science Translational Medicine
- Role of Focal Adhesion Kinase in Regulating YB–1–Mediated Paclitaxel Resistance in Ovarian Cancer
- (2013) Yu Kang et al. JNCI-Journal of the National Cancer Institute
- Microenvironmental regulation of tumor progression and metastasis
- (2013) Daniela F Quail et al. NATURE MEDICINE
- VEGF-Induced Vascular Permeability Is Mediated by FAK
- (2012) Xiao Lei Chen et al. DEVELOPMENTAL CELL
- Nanog Increases Focal Adhesion Kinase (FAK) Promoter Activity and Expression and Directly Binds to FAK Protein to Be Phosphorylated
- (2012) Baotran Ho et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Nuclear-localized focal adhesion kinase regulates inflammatory VCAM-1 expression
- (2012) Ssang-Taek Lim et al. JOURNAL OF CELL BIOLOGY
- Focal adhesion kinase and tumour angiogenesis
- (2011) Tanguy Lechertier et al. JOURNAL OF PATHOLOGY
- Conditional Deletion of the Focal Adhesion Kinase FAK Alters Remodeling of the Blood-Brain Barrier in Glioma
- (2010) J. Lee et al. CANCER RESEARCH
- Endothelial FAK is required for tumour angiogenesis
- (2010) Bernardo Tavora et al. EMBO Molecular Medicine
- Regulation of heterochromatin remodelling and myogenin expression during muscle differentiation by FAK interaction with MBD2
- (2009) Shi-Wen Luo et al. EMBO JOURNAL
- FAK nuclear export signal sequences
- (2008) Valeria Ossovskaya et al. FEBS LETTERS
- Nuclear FAK Promotes Cell Proliferation and Survival through FERM-Enhanced p53 Degradation
- (2008) Ssang-Taek Lim et al. MOLECULAR CELL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started